This pipeline maps genes, with mutation or copy number alteration AND this alteration is highly correlated with mRNA expression, to pathways curated in the KEGG and BIOCARTA databases. It identifies pathways significantly enriched with these genes. The pipeline also identifies pathways significantly enriched with marker genes of each expression subtype of cancer.
genes with mutation: identified by the Mutation_Significance pipeline
genes with copy number alteration: identified by the CopyNumber_Gistic2 pipeline
correlation between copy number and mRNA expression: identified by the Correlate_CopyNumber_vs_mRNA pipeline
marker genes and expression subtypes: identified by the mRNAConsensusClustering pipeline
There are 70 genes with significant mutation (Q value <= 0.1) and 213 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :
41 pathways significantly enriched with genes with copy number alteration or mutation.
0 pathways significantly enriched with marker genes of gene expression subtype 1
0 pathways significantly enriched with marker genes of gene expression subtype 2
1 pathways significantly enriched with marker genes of gene expression subtype 3
Pathway | Nof Genes | Nof CNV_Mut | Enrichment | P value | Q value |
---|---|---|---|---|---|
BIOCARTA_RACCYCD_PATHWAY | 26 | 7 | 4.3 | 0 | 0 |
BIOCARTA_PTEN_PATHWAY | 18 | 6 | 4.6 | 0 | 0 |
KEGG_ENDOMETRIAL_CANCER | 52 | 8 | 3.5 | 0 | 0 |
KEGG_PROSTATE_CANCER | 89 | 10 | 3.1 | 0 | 0 |
KEGG_CHRONIC_MYELOID_LEUKEMIA | 73 | 9 | 3.2 | 0 | 0 |
AKT1,PIK3CA,PIK3R1,TFDP1,RB1,CDKN1B,IKBKB
FOXO3,PTEN,AKT1,CDKN1B,PIK3CA,PIK3R1
FOXO3,PTEN,AKT1,PIK3CA,TP53,ERBB2,CDH1,PIK3R1
PTEN,AKT1,PIK3CA,TP53,RB1,FGFR2,ERBB2,PIK3R1,CDKN1B,IKBKB
AKT1,GAB2,PIK3CA,TP53,RB1,RUNX1,PIK3R1,CDKN1B,IKBKB
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
BIOCARTA_CYTOKINE_PATHWAY | 21 | 6 | 1.7 | 0.0076 | 0.2 |
BIOCARTA_HIVNEF_PATHWAY | 56 | 11 | 1.1 | 0.0083 | 0.2 |
BIOCARTA_MAPK_PATHWAY | 87 | 15 | 0.94 | 0.0081 | 0.2 |
BIOCARTA_TALL1_PATHWAY | 15 | 5 | 1.9 | 0.0072 | 0.2 |
KEGG_GLYCEROLIPID_METABOLISM | 49 | 11 | 1.3 | 0.0029 | 0.2 |
IL3,IL8,IL15,IL17A,IFNB1,LTA
NFKB1,MAP3K5,CASP9,DFFB,CYCS,MAP3K14,TRAF1,TRAF2,NUMA1,RASA1,PARP1
NFKB1,MAX,MAP3K5,MAP4K5,MAPK4,MAP3K14,MAP3K12,TRAF2,GRB2,ELK1,MAP4K1,CEBPA,TGFBR1,MEF2D,MAPK13
TRAF2,TNFRSF13B,NFKB1,MAP3K14,TRAF5
AGPAT6,AGPAT3,AGPAT1,PPAP2C,GALK2,DGKA,AGK,LCP1,DGKQ,DGKH,DGKZ
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_PURINE_METABOLISM | 158 | 26 | 0.91 | 0.001 | 0.33 |
KEGG_LYSOSOME | 121 | 20 | 0.93 | 0.0031 | 0.34 |
KEGG_ENDOCYTOSIS | 183 | 27 | 0.79 | 0.0027 | 0.34 |
KEGG_SPLICEOSOME | 126 | 19 | 0.94 | 0.0043 | 0.36 |
KEGG_HUNTINGTONS_DISEASE | 183 | 25 | 0.75 | 0.0058 | 0.38 |
ADCY4,SLC25A16,ADCY2,PDE3B,POLE,PDE4D,PRPS1,POLE2,ENTPD3,ENTPD2,GUCY2F,AK1,AK2,GUCY2C,PDE6G,NT5M,ADCY10,NT5E,IMPDH1,PDE10A,GUCY1B3,POLR2C,POLR3A,POLR3C,APRT,AMPD1
HGSNAT,AP4M1,NPC2,ACP5,CTSL1,SLC11A1,LAPTM5,CLTCL1,CLTA,AP1S3,AP1S1,CD164,DNASE2B,CTSE,AP1M1,PSAPL1,NAGPA,AP3M2,AP4S1,GGA1
STAM,HLA-A,FGFR4,STAM2,ADRBK2,ADRBK1,CHMP2B,EGF,IQSEC2,GIT1,PARD6A,EPS15,CBLC,HGS,CLTCL1,CLTA,IL8RA,IL8RB,AGAP2,RAB11FIP4,EPN2,EHD3,DNM3,VTA1,ARAP3,DNM1,ARAP1
CHERP,SNRPD2,SFRS7,PQBP1,LSM4,SFRS2,AQR,SNRPB2,ISY1,DHX8,DDX5,PLRG1,PRPF4,THOC2,THOC1,TRA2A,SF3B4,SF3B3,SYF2
TBP,COX5B,BDNF,CREB3L3,DCTN1,COX6B1,CREBBP,NDUFV3,NFE2L1,CLTCL1,CLTA,PPARG,UQCRFS1,CASP3,CASP9,ATP5H,NDUFS1,UQCRB,NDUFB8,NDUFB9,DNAH1,POLR2C,NDUFB1,SOD1,SDHD
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_WNT_SIGNALING_PATHWAY | 151 | 29 | 1.1 | 0 | 0.0095 |
KEGG_MISMATCH_REPAIR | 23 | 9 | 2.2 | 0.0001 | 0.011 |
KEGG_ENDOCYTOSIS | 183 | 31 | 0.98 | 0.0001 | 0.014 |
KEGG_ADHERENS_JUNCTION | 75 | 16 | 1.3 | 0.0004 | 0.032 |
KEGG_VEGF_SIGNALING_PATHWAY | 76 | 16 | 1.3 | 0.0006 | 0.035 |
PPP2R5C,CTNNB1,MAP3K7,WNT4,PRKACB,CUL1,WNT10B,CHP2,WNT5A,DAAM1,CACYBP,AXIN1,SMAD4,PLCB1,PPP2R1A,SIAH1,RUVBL1,NKD1,WNT16,APC2,NFAT5,PPP3CC,PPP3CA,NFATC2,CAMK2A,FZD8,GPI,FZD5,TBL1Y
SSBP1,LIG1,POLD3,RFC5,RFC4,RFC1,POLD1,POLD2,PMS2
CHMP4A,CHMP6,HLA-C,ARFGAP3,ARFGAP2,STAM2,ASAP3,SRC,CHMP2B,ADRB3,SNF8,TRAF6,IQSEC1,KDR,CBLC,NEDD4,SMURF2,PARD6G,SMURF1,PIP4K2B,LDLR,CDC42,UNC45A,CXCR4,EPN2,FLT1,AP2A2,RAB31,VPS24,DNM2,F2R
WASF2,LMO7,VCL,CTNNB1,MAP3K7,CDC42,INSR,PTPRJ,PTPRM,ACTN4,ACTN3,ERBB2,SRC,GPI,SMAD4,TJP1
CDC42,AKT2,CHP2,SH2D2A,PLA2G6,PLA2G5,SRC,PXN,JMJD7-PLA2G4B,NFAT5,PPP3CC,PPP3CA,NFATC2,PIK3R2,KDR,MAPK13
Let genes with copy number alteration or mutation be query genes. Let marker genes of specific identified subtypes be query genes. The Enrichment is calculated as:
-
Enrichment = log2 (# of query genes in the pathway/# No of query genes) - log2 (# of genes in the pathway/# of human genes)
The statistical signficance of the pathways that are enriched with genes with copy number alteration or mutation, and the pathways that are enriched with markers genes of specific identified subtypes is measured by P value.
-
P value = Fisher exact P value
The Q value is for adjusting P value for multiple testing. A public available R package is used to calculate the Q value.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.